| Q36400453 | A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae |
| Q33607295 | A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. |
| Q40038089 | A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories |
| Q28389388 | A survey of host range genes in poxvirus genomes |
| Q37002272 | A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. |
| Q39876668 | Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane |
| Q33782567 | Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses |
| Q42679073 | Analysis of the monkeypox virus genome |
| Q35857238 | Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex |
| Q42152788 | Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae). |
| Q37097672 | C4b-Binding protein, a regulatory protein of complement |
| Q35533657 | Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes |
| Q40011089 | Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack |
| Q36687208 | Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope |
| Q33804431 | Complement Evasion Strategies of Viruses: An Overview |
| Q37026644 | Complement driven by conformational changes |
| Q36705669 | Complement evasion strategies of microorganisms |
| Q40737570 | Complement-related proteins in pathogenic organisms |
| Q35176375 | Complement: structure, functions, evolution, and viral molecular mimicry |
| Q40866981 | Conservation in decay accelerating factor (DAF) structure among primates |
| Q33805943 | Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel [...] |
| Q34400002 | Control of the complement system. |
| Q27629908 | Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans |
| Q36699676 | Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor |
| Q35076706 | Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice |
| Q45710613 | Direct Binding of Herpes Simplex Virus Type 1 Virions to Complement C3 |
| Q35367093 | Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity |
| Q40578979 | Dose-dependent inhibition of complement in baboons by vaccinia virus complement control protein: implications in xenotransplantation |
| Q39171716 | Ectromelia virus N1L is essential for virulence but not dissemination in a classical model of mousepox. |
| Q34069057 | Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins |
| Q34230482 | Elucidating the role of the complement control protein in monkeypox pathogenicity |
| Q36018992 | Fighting cancer with vaccinia virus: teaching new tricks to an old dog. |
| Q60250695 | Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus |
| Q39577168 | Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. |
| Q40925056 | Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). |
| Q40372624 | Functional organization of variola major and vaccinia virus genomes |
| Q42672284 | Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus |
| Q41108660 | Genetic structure and organization of the membrane attack complement components |
| Q37452067 | Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5. |
| Q35216397 | Herpes and pox viral complement control proteins: 'the mask of self'. |
| Q41501380 | Highly attenuated poxviruses induce functional priming of neutrophils in vitro |
| Q34022959 | Host-related immunomodulators encoded by poxviruses and herpesviruses |
| Q71819208 | Human Complement Proteins C3b, C4b, Factor H and Properdin React with Specific Sites in gpl20 and gp4l, the Envelope Proteins of HIV1 |
| Q24675546 | Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41 |
| Q42664957 | Human monkeypox and smallpox viruses: genomic comparison. |
| Q35655365 | IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins |
| Q36682645 | Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence |
| Q33253097 | Identification and sequence analysis of four complement factor H-related transcripts in mouse liver |
| Q30447940 | Identification of complement regulatory domains in vaccinia virus complement control protein |
| Q36498115 | Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation |
| Q37302488 | Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence |
| Q38715016 | Immunomodulating Drugs Based on Poxviral Proteins |
| Q45453302 | Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains |
| Q30339052 | Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. |
| Q28972389 | Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy |
| Q45851827 | Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues |
| Q39611097 | Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity |
| Q37075440 | Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood |
| Q40038846 | Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. |
| Q30482705 | Investigation of interaction of vaccinia virus complement control protein and curcumin with complement components c3 and c3b using quartz crystal microbalance with dissipation monitoring technology |
| Q52676786 | Ixodes ticks belonging to the Ixodes ricinus complex encode a family of anticomplement proteins. |
| Q37348541 | Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. |
| Q41381066 | Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. |
| Q43678006 | Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance |
| Q34064310 | Microbial subversion of the immune response |
| Q50533334 | Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory. |
| Q37776790 | Modulation of the host immune response by cowpox virus |
| Q40641469 | Molecular mimicry. |
| Q37287795 | Monkeypox virus and insights into its immunomodulatory proteins |
| Q33650182 | Murine gammaherpesvirus 68 encodes a functional regulator of complement activation |
| Q41355397 | Myxoma T2 protein as a model for poxvirus TNF receptor homologs |
| Q55314189 | New insights into the immunomodulatory properties of poxvirus cytokine decoy receptors at the cell surface. |
| Q40066082 | New member of the multigene family of complement control proteins in herpesvirus saimiri |
| Q38824720 | Novel Evasion Mechanisms of the Classical Complement Pathway. |
| Q21285044 | Orthopoxvirus genes that mediate disease virulence and host tropism |
| Q42657008 | Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network |
| Q45394220 | Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes |
| Q36599545 | Potentially lethal bacterial infection associated with varicella zoster virus |
| Q33899303 | Poxviral mimicry of complement and chemokine system components: what's the end game? |
| Q34190609 | Poxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein |
| Q34055804 | Poxvirus homologues of cellular genes |
| Q34151409 | Poxvirus immune modulators: functional insights from animal models |
| Q35125981 | Poxvirus immunomodulatory strategies: current perspectives |
| Q24634729 | Poxvirus pathogenesis |
| Q36701076 | Primary structure of the herpesvirus saimiri genome |
| Q45306432 | Pro-inflammatory complement activation by the A beta peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein |
| Q45701883 | Prolonged retention of vaccinia virus complement control protein following IP injection: implications in blocking xenorejection |
| Q38991019 | Protection of host cells by complement regulators. |
| Q35155228 | Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein |
| Q33780579 | Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. |
| Q28288029 | Shuffled domains in extracellular proteins |
| Q33972574 | Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity |
| Q37414122 | Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment |
| Q34780607 | Smallpox vaccines: targets of protective immunity |
| Q43838742 | Species-specific differences in organization of orthopoxvirus kelch-like proteins |
| Q74629156 | Species-specific differences in the organization of the complement-binding protein of orthopoxviruses |
| Q42662567 | Species-specific differences in the structure of orthopoxvirus complement-binding protein |
| Q33937787 | Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor |
| Q46639843 | Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein |
| Q34454009 | Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). |
| Q34829635 | Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation |
| Q41710756 | Structure, functions, and evolution of the third complement component and viral molecular mimicry |
| Q37097678 | Subversion of complement by hematophagous parasites |
| Q27488882 | The Paramyxoviruses Simian Virus 5 and Mumps Virus Recruit Host Cell CD46 To Evade Complement-Mediated Neutralization |
| Q34742926 | The Vaccinia virus complement control protein modulates adaptive immune responses during infection |
| Q34434747 | The agnoprotein of polyomavirus JC is released by infected cells: evidence for its cellular uptake by uninfected neighboring cells. |
| Q39870476 | The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity |
| Q45476049 | The gene of the complement-binding protein, an important anti-inflammatory factor of orthopoxviruses, is deleted from the genome of Western African strains of monkeypox virus. |
| Q42615527 | The genomic sequence of ectromelia virus, the causative agent of mousepox |
| Q68860041 | The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46 |
| Q45753724 | The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation |
| Q37099581 | The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system |
| Q87098753 | The live vector approach-viruses |
| Q36166659 | The mechanism by which microorganisms avoid complement attack |
| Q36652057 | The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium |
| Q35886322 | The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines |
| Q38665434 | The regulators of complement activation (RCA) gene cluster |
| Q35963805 | The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins |
| Q36728801 | Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design |
| Q35122629 | Vaccinia complement control protein: Multi-functional protein and a potential wonder drug |
| Q24319056 | Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein |
| Q45729783 | Vaccinia virus complement control protein ameliorates hyperacute xenorejection by inhibiting xenoantibody binding |
| Q43651613 | Vaccinia virus complement control protein inhibits hyperacute xenorejection |
| Q45723011 | Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation |
| Q45731552 | Vaccinia virus complement control protein is monomeric, and retains structural and functional integrity after exposure to adverse conditions |
| Q45662592 | Vaccinia virus complement control protein modulates inflammation following spinal cord injury |
| Q36791349 | Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence |
| Q36780589 | Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily |
| Q37051617 | Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement |
| Q33538295 | Vaccinia virus immune evasion |
| Q73992874 | Vaccinia virus immune evasion |
| Q33834391 | Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity |
| Q39707773 | Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention |
| Q45859752 | Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon |
| Q34066011 | Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement |
| Q35206879 | Variola virus immune evasion proteins |
| Q33256210 | Venom and viral expression products of the endoparasitic wasp Campoletis sonorensis share epitopes and related sequences |
| Q33688595 | Viral complement regulatory proteins |
| Q35122624 | Viral mimicry of the complement system |
| Q38995165 | Viral-derived complement inhibitors: current status and potential role in immunomodulation |
| Q34451942 | Virokines: novel immunomodulatory agents |
| Q45435690 | Virulence differences between monkeypox virus isolates from West Africa and the Congo basin |
| Q52529375 | [Virus-bacteria co-infections] |